BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15257034)

  • 1. MDR-1 C3435T polymorphism influences cyclosporine a dose requirement in liver-transplant recipients.
    Bonhomme-Faivre L; Devocelle A; Saliba F; Chatled S; Maccario J; Farinotti R; Picard V
    Transplantation; 2004 Jul; 78(1):21-5. PubMed ID: 15257034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients.
    von Ahsen N; Richter M; Grupp C; Ringe B; Oellerich M; Armstrong VW
    Clin Chem; 2001 Jun; 47(6):1048-52. PubMed ID: 11375290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation.
    Azarpira N; Aghdaie MH; Behzad-Behbahanie A; Geramizadeh B; Behzadi S; Malekhoseinie SA; Raisjalal GH; Rahsaz M; Pourgholami A; Sagheb F
    Exp Clin Transplant; 2006 Jun; 4(1):416-9. PubMed ID: 16827636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients.
    Qiu XY; Jiao Z; Zhang M; Zhong LJ; Liang HQ; Ma CL; Zhang L; Zhong MK
    Eur J Clin Pharmacol; 2008 Nov; 64(11):1069-84. PubMed ID: 18636247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant impact of gene polymorphisms on tacrolimus but not cyclosporine dosing in Asian renal transplant recipients.
    Loh PT; Lou HX; Zhao Y; Chin YM; Vathsala A
    Transplant Proc; 2008 Jun; 40(5):1690-5. PubMed ID: 18589174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism in the P-glycoprotein drug transporter MDR1 gene in renal transplant patients treated with cyclosporin A in a Polish population.
    Kotrych K; Sulikowski T; Domański L; Białecka M; Droździk M
    Pharmacol Rep; 2007; 59(2):199-205. PubMed ID: 17556798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of ABCB1 C3435T Polymorphism on Cyclosporine Dose Requirements in Kidney Transplant Recipients: A Meta-Analysis.
    Lee J; Wang R; Yang Y; Lu X; Zhang X; Wang L; Lou Y
    Basic Clin Pharmacol Toxicol; 2015 Aug; 117(2):117-25. PubMed ID: 25536375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Multidrug-Resistant 1 (MDR1) and CYP3A4*1B Polymorphisms on Cyclosporine-Based Immunosuppressive Therapy in Renal Transplant Patients.
    Kotowski MJ; Bogacz A; Bartkowiak-Wieczorek J; Tejchman K; Dziewanowski K; Ostrowski M; Czerny B; Grześkowiak E; Machaliński B; Sieńko J
    Ann Transplant; 2019 Feb; 24():108-114. PubMed ID: 30799432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients.
    Crettol S; Venetz JP; Fontana M; Aubert JD; Pascual M; Eap CB
    Ther Drug Monit; 2008 Dec; 30(6):689-99. PubMed ID: 18978522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-blood cultures from renal-transplant patients stimulated ex vivo show that the effects of cyclosporine on lymphocyte proliferation are related to P-glycoprotein expression.
    Singh D; Alexander J; Owen A; Rustom R; Bone M; Hammad A; Roberts N; Park K; Pirmohamed M
    Transplantation; 2004 Feb; 77(4):557-61. PubMed ID: 15084935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in CYP3A5, CYP3A4, and ABCB1 are not associated with cyclosporine pharmacokinetics nor with cyclosporine clinical end points after renal transplantation.
    Bouamar R; Hesselink DA; van Schaik RH; Weimar W; Macphee IA; de Fijter JW; van Gelder T
    Ther Drug Monit; 2011 Apr; 33(2):178-84. PubMed ID: 21383650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP-binding cassette subfamily B member 1 polymorphisms do not determine cyclosporin exposure, acute rejection or nephrotoxicity after heart transplantation.
    Taegtmeyer AB; Breen JB; Smith J; Burke M; Leaver N; Pantelidis P; Lyster H; Yacoub MH; Barton PJ; Banner NR
    Transplantation; 2010 Jan; 89(1):75-82. PubMed ID: 20061922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Explaining variability in ciclosporin exposure in adult kidney transplant recipients.
    Press RR; Ploeger BA; den Hartigh J; van der Straaten T; van Pelt H; Danhof M; de Fijter H; Guchelaar HJ
    Eur J Clin Pharmacol; 2010 Jun; 66(6):579-90. PubMed ID: 20354687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine.
    Aleksic I; Baryalei M; Busch T; Pieske B; Schorn B; Strauch J; Sîrbu H; Dalichau H
    Transplantation; 2000 Apr; 69(8):1586-90. PubMed ID: 10836367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation.
    Goto M; Masuda S; Saito H; Uemoto S; Kiuchi T; Tanaka K; Inui K
    Pharmacogenetics; 2002 Aug; 12(6):451-7. PubMed ID: 12172213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patients.
    Yates CR; Zhang W; Song P; Li S; Gaber AO; Kotb M; Honaker MR; Alloway RR; Meibohm B
    J Clin Pharmacol; 2003 Jun; 43(6):555-64. PubMed ID: 12817518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients.
    Sharaki O; Zeid M; Moez P; Zakaria NH; Nassar E
    Mol Biol Rep; 2015 Jan; 42(1):105-17. PubMed ID: 25240575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDR1 gene polymorphism in allogeenic kidney transplant patients with tremor.
    Kotrych K; Domański L; Górnik W; Droździk M
    Pharmacol Rep; 2005; 57(2):241-5. PubMed ID: 15886424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of multidrug resistance 1 gene polymorphism on tacrolimus dose and concentration-to-dose ratio in Chinese liver transplantation recipients.
    Jin J; Wu LH; Wang WL; Yu SF; Yan S; Zheng SS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):616-20. PubMed ID: 16331555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diltiazem augments the influence of MDR1 genotype status on cyclosporine concentration in Chinese patients with renal transplantation.
    Wang YX; Li JL; Wang XD; Zhang Y; Wang CX; Huang M
    Acta Pharmacol Sin; 2015 Jul; 36(7):855-62. PubMed ID: 25891084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.